0001217234-23-000160.txt : 20230713
0001217234-23-000160.hdr.sgml : 20230713
20230713205646
ACCESSION NUMBER: 0001217234-23-000160
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230713
FILED AS OF DATE: 20230713
DATE AS OF CHANGE: 20230713
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Seeto Reginald
CENTRAL INDEX KEY: 0001688485
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36536
FILM NUMBER: 231087830
MAIL ADDRESS:
STREET 1: C/O ARDELYX, INC.
STREET 2: 34175 ARDENWOOD BLVD, SUITE 200
CITY: FREMONT
STATE: CA
ZIP: 94555
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CareDx, Inc.
CENTRAL INDEX KEY: 0001217234
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 943316839
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 8000 MARINA BLVD
STREET 2: 4TH FLOOR
CITY: BRISBANE
STATE: CA
ZIP: 94005
BUSINESS PHONE: 415-287-2300
MAIL ADDRESS:
STREET 1: 8000 MARINA BLVD
STREET 2: 4TH FLOOR
CITY: BRISBANE
STATE: CA
ZIP: 94005
FORMER COMPANY:
FORMER CONFORMED NAME: XDx, Inc.
DATE OF NAME CHANGE: 20071010
FORMER COMPANY:
FORMER CONFORMED NAME: EXPRESSION DIAGNOSTICS INC
DATE OF NAME CHANGE: 20030203
4
1
wf-form4_168929619308128.xml
FORM 4
X0407
4
2023-07-13
0
0001217234
CareDx, Inc.
CDNA
0001688485
Seeto Reginald
C/O CAREDX, INC.
8000 MARINA BOULEVARD, 4TH FLOOR
BRISBANE
CA
94005
1
1
0
0
See Remarks
0
Common Stock
2023-07-13
4
S
0
5260
10.3341
D
488870
D
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2022.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.11 to $10.71, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
Includes 815 shares acquired pursuant to the Issuer's 2014 Employee Stock Purchase Plan.
President and Chief Executive Officer.
/s/ Reginald Seeto
2023-07-13